Dr. Arnoletti is a nationally recognized, board-certified general surgeon who focuses on cancers of the pancreas, liver and bile ducts, stomach and bowel. Additional specialties include spleen disorders, adrenal tumors and soft tissue sarcomas. A recognized authority in his field, Dr. Arnoletti is the current Chief of Surgical Oncology at AdventHealth Orlando (formerly Florida Hospital Orlando).
A graduate of the University of the Republic Medical School in Montevideo, Uruguay, Dr. Arnoletti undertook his residency training at MCP-Hahnemann University in Philadelphia followed by his advanced fellowship in surgical oncology at Fox Chase Cancer Center in the same city. He arrived in Central Florida from Birmingham, AL, where he previously served as an associate professor of surgery and director of the Surgical Oncology Laboratory at the University of Alabama at Birmingham (UAB) and as clinical core director of the UAB Pancreatic Cancer Program.
Dr. Arnoletti has built a reputation for his leading research in cancer care, including groundbreaking discoveries as part of the National Cancer Institute Specialized Program of Research Excellence (SPORE), and has authored more than 60 peer-reviewed articles in medical publications. Dr. Arnoletti leads ongoing research projects in pancreatic cancer at AdventHealth Translational Research Institute and is a member of the Florida Collaborative Pancreatic Cancer Research Group. Dr. Arnoletti also serves as the AdventHealth Cancer Institute Liaison Physician for the American College of Surgeons Commission on Cancer. His outstanding reputation and patient reviews have earned him “Best Doctor” and “Top Doctor” recognitions by both Birmingham Magazine and Orlando Magazine.
